Skip to content
Search resources Open menu

Tag

malingering

Validity Indicator Profile (VIP)

The Validity Indicator Profile (VIP) evaluates response style to help determine whether psychological test results reflect a test-taker’s actual effort and can be interpreted as representative of their abilities. The source describes its use as a validity indicator alongside other tests, explains that its validity classifications do not measure ability, and gives an intended age range of 18 to 69 years with an approximately one-hour administration.

Test of Memory Malingering  (TOMM)

The Test of Memory Malingering (TOMM) is a visual recognition measure used as an initial part of a broader psychological assessment of claimed memory impairment. Its 50 items are intended to help distinguish deliberate exaggeration from genuine memory problems, and the source describes it for people age 16 and older with an administration time of approximately 15 to 25 minutes.

EVALUATION: Malingering

This article presents the DSM description of malingering as the intentional production or exaggeration of symptoms for an external incentive. It lists circumstances that may raise suspicion and distinguishes malingering from factitious and conversion disorders by motivation, intentionality, and the presence of external incentives.

Miller Forensic Assessment of Symptoms Test (M-FAST)

The Miller Forensic Assessment of Symptoms Test (M-FAST) is a brief screening interview for adults that gathers preliminary information about possible feigning of psychiatric symptoms. Its 25 items address patterns such as unusual symptom combinations, extreme reports, and discrepancies between reported and observed behavior, with several single-item indicators requiring cautious interpretation.

PTSD: Malingering

The articles examine feigned or simulated PTSD, assessment challenges, and the distinction between malingering and factitious presentations. A simulation study found that direct trauma exposure was associated with somewhat greater reported PTSD severity than indirect exposure, while symptom-validity profiles showed little difference apart from the total screening score.